Atea Pharmaceuticals, Inc.
Beta-d-2'-deoxy-2'-alpha-fluoro-2'-beta-c-substituted-4'fluoro-n6-substitu- ted-6-amino-2-substituted purine nucleotides for the treatment of hepatitis c virus infection

Abstract:

Compounds of Formula I, Formula II, Formula III, Formula IV, Formula V, Formula VI, Formula VII, Formula VIII, Formula IX and Formula X that are highly active against the HCV virus when administered in an effective amount to a host in need thereof. The host can be a human or any animal that carries the viral infection. Methods of treating a subject suffering from a condition related to viral infections are also provided.